Form 8-K - Current report:
SEC Accession No. 0001157523-11-002686
Filing Date
2011-05-04
Accepted
2011-05-04 08:00:17
Documents
2
Period of Report
2011-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CELLDEX THERAPEUTICS, INC. 8-K a6707842.htm 8-K 16563
2 EXHIBIT 99.1 a6707842ex99_1.htm EX-99.1 52020
  Complete submission text file 0001157523-11-002686.txt   69879
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 11808196
SIC: 2835 In Vitro & In Vivo Diagnostic Substances